Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

Yi Rang Kim, Dok Hyun Yoon, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Changhoon Yoo, Jeong-eun Kim, Jae-Cheol Jo, Jooryung Huh, Jeong Hoon Kim, Sang-wook Lee, Cheolwon Suh

Blood (2014) 124 (21): 1190.

https://doi.org/10.1182/blood.V124.21.1190.1190

Published: 2014

Journal Articles

Comparison of Survival and Clinical Features In Different Age Cohorts of Patients with Multiple Myeloma: A Single Center Experience

Jae Ho Jeong, MD, Shinkyo Yoon, MD, Dalyong Kim, MD, Jeong Eun Kim, MD, Dok Hyun Yoon, MD, Shin Kim, RN, Cheolwon Suh, MD

Blood (2010) 116 (21): 4997.

https://doi.org/10.1182/blood.V116.21.4997.4997

Published: 2010

Journal Articles

Interim Report of Phase II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients with Disseminated Stage Diffuse Large B-Cell Lymphoma.

Jeong Eun Kim, MD, Dae Ho Lee, M.D., Soon Il Lee, Jae Hoon Lee, Won Seog Kim, Bora Yoon, Cheolwon Suh, MD

Blood (2009) 114 (22): 2688.

https://doi.org/10.1182/blood.V114.22.2688.2688

Published: 2009

Journal Articles

Prognostic Impact of Mid-Treatment PET in Patients with Diffuse Large B-Cell Lymphoma Who Achieved Metabolic CR at Post-Treatment PET

Changhoon Yoo, Jeong-Eun Kim, MD, Byeong Seok Sohn, MD, Dok Hyun Yoon, MD, Shin Kim, Dae Ho Lee, M.D., Sang We Kim, Jung Shin Lee, M.D., Cheolwon Suh

Blood (2009) 114 (22): 3949.

https://doi.org/10.1182/blood.V114.22.3949.3949

Published: 2009

Journal Articles

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

Jeong-Eun Kim, Cheolwon Suh, MD, Yunsuk Choi, Eun Kyoung Kim, Byeong Seok Sohn, Inkeun Park, Dok Hyun Yoon, Changhoon Yoo, Geundoo Jang, Shin Kim, Dae Ho Lee, Sang -We Kim, Jung Shin Lee

Blood (2008) 112 (11): 4439.

https://doi.org/10.1182/blood.V112.11.4439.4439

Published: 2008

NARROW

Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

Comparison of Survival and Clinical Features In Different Age Cohorts of Patients with Multiple Myeloma: A Single Center Experience

Interim Report of Phase II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients with Disseminated Stage Diffuse Large B-Cell Lymphoma.

Prognostic Impact of Mid-Treatment PET in Patients with Diffuse Large B-Cell Lymphoma Who Achieved Metabolic CR at Post-Treatment PET

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

Email alerts

ASH Publications

American Society of Hematology

Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

Comparison of Survival and Clinical Features In Different Age Cohorts of Patients with Multiple Myeloma: A Single Center Experience

Interim Report of Phase II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients with Disseminated Stage Diffuse Large B-Cell Lymphoma.

Prognostic Impact of Mid-Treatment PET in Patients with Diffuse Large B-Cell Lymphoma Who Achieved Metabolic CR at Post-Treatment PET

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only